Trial Profile
Phase I/II study of LY231514 [pemetrexed] plus cisplatin in patients with malignant pleural mesothelioma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 30 Jan 2007
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Malignant-mesothelioma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Eli Lilly and Company
- 27 Jan 2007 Status change
- 24 Dec 2005 New trial record.